PNPLA1
protein-codingpatatin like phospholipase domain containing 1, the group of Patatin like phospholipase domain containing
Gene summary
The protein encoded by this gene belongs to the patatin-like phospholipase (PNPLA) family, which is characterized by the presence of a highly conserved patatin domain. PNPLA family members have diverse lipolytic and acyltransferase activities, and are key elements in lipid metabolism. While other members of this family have been well characterized, the function of this gene remained an enigma. However, recent studies show that this gene is expressed in the skin epidermal keratinocytes, and has a role in glycerophospholipid metabolism in the cutaneous barrier. Consistent with these observations, mutations in this gene are associated with ichthyosis in human (autosomal recessive congenital ichthyoses, ARCI) and dog. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2012]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~70.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014011
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0019306
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014011
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014011
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0014011
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014011
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Dermatologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PNPLA1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001374623.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 34 | 2 | 39 | ||
| missense | 11 | 22 | 105 | 15 | 5 | 158 |
| nonsense | 2 | 5 | 1 | 1 | 9 | |
| start loss | 0 | |||||
| frameshift | 4 | 5 | 1 | 10 | ||
| splice donor/acceptor (+/-2bp) | 1 | 5 | 6 | |||
| Total | 18 | 37 | 110 | 50 | 7 | 222 |
Highest pathogenic variant AF is 0.00007893637
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001361552.1 | 9 | MANE Select | |
| Ensembl | ENSP00000490785.2 | 9 | MANE Select | |
| RefSeq | NP_001139188.1 | 7 | Standard | |
| RefSeq | NP_001139189.2 | 8 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- triglyceride catabolic process
- lipid homeostasis
Molecular Function
- triglyceride lipase activity
Cellular Component
- cytoplasm
- lipid droplet
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000394571
- Coding exons
- 8
- Length
- 65393
- Individuals with no LoFs
- 125719
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 29
- Defined
- 125748
- p
- 0.000115
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.734 | 283 | 320 | 0.884 | 0.0000189 | 3395 |
| Missense (PolyPhen) | 88 | 114.93 | 0.76565 | 1123 | ||
| Synonymous | -0.815 | 153 | 141 | 1.09 | 0.00000947 | 1142 |
| Loss of Function | 2.47 | 10 | 22.7 | 0.441 | 0.00000130 | 237 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00037 | 0.00037 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00017 | 0.00017 | rare |
| South Asian | 0.000065 | 0.000065 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Lipid hydrolase. Important in the formation of the epidermal lipid barrier. Plays a role in glycerophospholipid metabolism. {ECO:0000269|PubMed:22246504}.;
Intolerance Scores
- LoFtool
- 0.745
- RVIS EVS
- 1.27
- RVIS percentile EVS
- 93.63
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.0685
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |